Prof. Stefano Fiorucci is a professor of Gastroenterology at the University of Perugia. He is the author of over 350 full papers. He is the director of gastroenterology unit in the Department of Surgical and Biomedical sciences. Professor Fiorucci investigates FXR Nuclear Receptors (Farnesoid-X-Receptor), PXR (Pregnane-X-Receptor) and PPARs (Peroxisome Proliferator-Activated Receptors) and the role they play in the onset and evolution of certain pathologies, such as chronic inflammatory bowel disease (IBD), Crohn's disease and several liver disorders (NASH, cholestasis). During his career he has published over 300 manuscripts in major international scientific journals.
Prof. Madhav Bhatia heads the Inflammation Research Group in the Department of Pathology at the University of Otago, Christchurch. The group has an active research programme on the molecular pharmacology and molecular pathology of various inflammatory conditions such as acute pancreatitis, polymicrobial sepsis and burns, with the long-term goal of developing clinically effective therapeutic approaches. He has received numerous grants, has authored more than 160 contributions to the peer-reviewed literature, given several invited presentations in different countries and is on Editorial Boards of 34 journals. His publications have been cited more than 8000 times, and he has an "h"-index of 47. Prof. Bhatia has delivered invited talks at several international conferences worldwide. Prof. Bhatia has mentored several postgraduate students have now become research staff, who are now independent investigators and leading research groups in different parts of the world.
Dr. La Cava obtained M.D. and Ph.D. degrees from the University of Naples, Italy. Currently, Dr. La Cava is a Professor at the David Geffen School of Medicine at the University of California Los Angeles (UCLA) and is the Director of the FOCIS Center of Excellence at UCLA. He has published more than 150 scientific publications and is currently in the editorial board of many scientific journals including this one.
Dr. Ramana obtained a doctorate (Ph.D.) in Biochemistry from the Postgraduate Institute of Medical Research, Chandigarh, India. Currently, he is a Professor in the Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. The chief objectives of his investigations are to examine the involvement of cellular metabolism and oxidative stress signals in inflammation and to delineate the role of aldo-keto reductases and anti-oxidants in mediating the inflammatory pathways. He has published more than 100 peer reviewed articles. He is also serving as an editorial board member of several journals.
Jean-Marc SABATIER is the Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also the Director of Research for several French private companies as well as a Canadian public company. He acts as a consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry. He is a member of 35 Editorial Boards of scientific journals. He is also a member of a number of scientific societies.
Dr. Kuldeep Dhama, is a regional editor for the journal. Currently, he is working as Principal Scientist in ICAR-Indian Veterinary Research Institute, India. With 22 years of research and teaching experience in the areas of immunology, microbiology and virology, he has developed several diagnostics, vaccines and immunomodulatory modules to counter infectious diseases of animals and public health concerns. He has 800 publications in scientific journals, books, magazines; is a member of 20 professional/scientific societies; and honored with 50 Best Paper Awards and other high recognitions. He worked as Nodal Officer, WTO; Member, Wildlife Health Specialist Group (IUCN); and is an Editor and Board member in reputed journals. Besides, he is a peer-reviewer for several journals. His h-index is 35 with 6150 citations.
Dr. Giuseppe Murdaca, M.D. (1993), Ph.D. (2003), is currently an Associate Professor of Internal Medicine, in the Department of Internal Medicine and Medical Specialties, at the University of Genova, Italy. His research interests involve Immunodeficiency, Autoimmunity, Neuro-endocrino-immunology, Pharmacogenomics, and Vaccine and autoimmune diseases. Dr. Murdaca has authored/co-authored over 90 article publications in various journals, having a significant number of total citations, i.e. more than 1,870. He has membership in Italian Society of Immunology, Clinical Immunology and Allergy, Italian Society of Internal Medicine, and Italian Society of Experimental Biology. Furthermore, he is the Editor-in-Chief of several other journals, i.e. Edorium Journal of Medicine, Autoimmune Diseases and Therapeutic Approaches: Open Access, Journal of Immunization, etc.
Dr. Marco Tutone received his Ph.D. degree in pharmaceutical sciences in 2006. From 2006 to 2008, he was a Post-doc research fellow at the University of Palermo. In October 2019, he became an associate professor of medicinal chemistry at the University of Palermo. His research activity focuses on computational medicinal chemistry. In recent years, he has also been focusing on the study of natural substances along with the design, synthesis and biological evaluation of dopaminergic modulators. Since 2014, he has been involved in the study of TRIDs and he is also the owner of an international patent.
Dr. Hardeep Singh Tuli is an Assistant Professor in the Department of biotechnology Maharishi Markandeshwar University India. From 2009 to 2011, he was a Lecturer in the Department of Applied Sciences, Institute of Science and Technology, Klawad, India. To date, he has published more than 90 papers in various peer-reviewed international journal and authored or co-authored in a number of book chapters. He has published a couple of books. He also edited thematic issues on "Natural Moieties as Anti-Inflammatory Agents-Recent Patents" & “Current Aspects in Chemopreventive Strategies” with Recent Patents on Inflammation & Allergy Drug Discovery and Frontiers in Pharmacology respectively. One of his published articles was accepted as short news in the Italian Magazine, Laboratorio 2000.
Prof. Bei is M.D., and Ph.D. He is a specialist in Medical Oncology and in Clinical Pathology. Currently, he is Full Professor of General Pathology at the University of Rome “Tor Vergata”. His teaching activity encompasses General Pathology for School of Medicine, Medical Biotechnology, Pharmacy, Dietician, Residency in Endocrinology, Oncology. He is a editorial board member of Rec. Pat Infl Allergy Drug Discov, J Liver, MOJ Immunol (Senior Editor), O J Immunol, J Immun Serum Biol, SciTz Nutrition and Food Science, Frontiers in Bioscience, Anti-Cancer Agents in Med Chem. Research interest: Cancer immunotherapy. Nutrition and cancer. He has published about 100 peer reviewed publications with Total IF=375 (ISI), H-index: 29, and Citations: 2760.
She graduated in Medicine in 1977 from the Rome University "Sapienza" and specialized in Pediatrics in 1980 and in Childcare in 1985. For over 25 years, she has been interested in pediatric allergy and for more than 10 years she has begun her personal journey in Molecular Allergology. She has performed some fundamental studies on markers of severity of food allergy in children, mainly in cow's milk, egg, and plant food allergy. In collaboration with other CAAM (Centri Associati Allergologia Molecolare) members and researchers from other research centers, she has identified and characterized new allergenic molecules and, thanks to microarray-based diagnostics, she has set new molecular profiles of awareness leading to innovative schemes for therapeutic intervention in the allergic child. Dr.ssa Alessandri has published more than 80 scientific publications. She is a co-founder of CAAM, sharing the spirit and philosophy, contributing to its organization and its development. Together with other CAAM specialists she contributes to the design and release of the second generation molecule-based test for allergy diagnosis, the FABER IgE test.
Prof. Antonelli is currently the Director of the Immuno-Endocrine Section of Internal Medicine and Associate Professor in the Department of Clinical and Experimental Medicine, University of Pisa, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy. He graduated in Medicine cum laude from the University of Pisa in 1982, where he received the post-graduate Specialization in Endocrinology in 1985 and in Occupational Health in 1987. He also received the postgraduate Specialization in Oncology from the University La Sapienza, Rome, Italy in 1992. His researches have been published in more than 310 articles on International journals with an Impact Factor > 1190; and an H index 58.
Peter Barnes is a Margaret-Turner Warwick Professor of Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College and Honorary Consultant Physician at Royal Brompton Hospital, London. He qualified from Cambridge and Oxford Universities (first class honours) and was appointed to his present post in 1987. He has published >1000 peer-review papers on asthma, COPD and related topics (h-index 155) and has written or edited over 50 books. He is listed as the top 20 most highly cited researchers in the world and the most highly cited respiratory researcher in the world over the last 20 years. He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for over 150 years. He was President of the ERS in 2013/2014.
Dr. Salvatore is a Full Professor of Pharmacology, School of Medicine, University of Messina. He graduated in Pharmacy and Medicine and is an Honorary Professor in Pharmacology, University of Manchester (UK). Prof. Cuzzocrea received a doctorate (PhD) in “Experimental Medicine” School of Medicine University of Messina. He is the author of more than 600 publications including articles in peer reviewed international journals and scientific books. Editor and referee for several international journals. He encompasses research activities with specific competences at international levels in the field of autoimmunity, inflammation and neurodegenerative disorders as well as drug development.
Silvia Martina Ferrari graduated in Biological Sciences cum laude in 2002 and specialized in Clinical Pathology in 2007 from the University of Pisa (Italy). Her principal areas of expertise are autoimmune thyroid disorders, chemokines and cytokines, type 1 diabetes, systemic autoimmune disorders, HCV-associated thyroid disorders and thyroid cancer. Her research studies have been published in more than 154 articles on International journals (HI=38). She serves as an editorial board member and a referee and reviewer in a number of scientific international journals.
Dr. Foti had been working at the University of Bari as Associate Professor in Dermatology since 1998. Nowadays, she is the Director of the Dermatology Clinic at the University of Bari, President of the Italian Society of Dermatology, Allergology, Environmental and Professional (SIDAPA), member of the European Environmental and Contact Dermatitis Research Group (EECDRG). She is the author of over 200 scientific publications in national and international journals, 32 chapters and a monograph on various topics. Her main scientific interests are in the study of contact dermatitis, photo-dermatitis and urticaria. Her scientific activity is focused to the research of the substances responsible of contact allergy trying also to identify new sensitizing haptens.
Dr. Oreste Gualillo graduated in pharmaceutical chemistry and technology from the School of Pharmacy at the University “Federico II” in Naples, Italy. He obtained his Ph.D in Pharmacology in 1995. He received training in molecular endocrinology under the mentoring of Professor Paul A. Kelly from the Necker School of Medicine, INSERM U344, in ParisIn 2001, he set up his own research group at the Santiago University Clinical Hospital, Division of Rheumatology. He is currently a Staff Researcher of the Spanish National Heath System at Santiago University Clinical Hospital, heading the Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID) group of IDIS. He worked on the regulation and signal transduction of prolactin, leptin and ghrelin under various pathophysiological conditions, in particular in immunity and inflammation. Since 2001, Dr. Gualillo’s primary research is focused on the molecular signals triggered by adipokines and on the pathways through which adipokines are involved in rheumatic diseases and in the inflammatory response of chondrocytes, synovial cells and adipocytes in particular in osteoarthritis and rheumatoid arthritis. Dr. Gualillo’s track record of professional achievement is backed up by more than 150 primary peer-reviewed publications such as research papers, book chapters, editorials etc. He serves on the editorial boards of several scientific journals and committees as well as technical advisory bodies.
Dr. Hon is a paediatric professor at the Chinese University of Hong Kong. He received his undergraduate medical education from the University of Western Australia. He is a Fellow of the American Academy of Pediatricians (FAAP) and Fellow of Critical Care Medicine (FCCM). He received his Doctor of Medicine (MD) from the Chinese University of Hong Kong. Dr. Hon has published more than 300 peer-reviewed scientific papers, books and book chapters. Dr. Hon is particularly keen in educating the parents to dismiss myths and fallacies regarding the wellbeing and health of their children.
Dr. Leung obtained his MBBS in 1973 from the University of Hong Kong, Prof. Leung was an intern at the Queen Mary Hospital. He then completed his Pediatric residency followed by a Fellowship in Pediatric Endocrinology at the Foothills Provincial Hospital with the University of Calgary. Prof. Leung is Clinical Professor of Pediatrics at the University of Calgary and is Pediatric Consultant at the Alberta Children’s Hospital in Calgary, Alberta, Canada. Prof. Leung’s areas of interest include general pediatrics and pediatric endocrinology. Prof. Leung is the author of over 1000 scientific publications including 335 chapters and 9 books. Currently, Prof. Leung serves on the editorial boards of 36 medical journals.
Dr. Lixin Liu had research training with Dr. Dirk Roos at CLB, The Netherlands and completed his PhD study with Dr. Per Venge at Uppsala University Sweden. In 2001 as a post-doctoral fellow, he joined the lab of Dr. Paul Kubes in the University of Calgary, AB, Canada. In 2006, he joined the faculty at the University of Saskatchewan Saskatoon, SK, Canada and currently he is an associate professor in pharmacology. Using intravital microscopy and other techniques, his lab is now investigating the role of intracellular signaling molecules in neutrophil-endothelial cell interactions and neutrophil recruitment during inflammation.
Dr. Marrakchi graduated (MD) from the University of Brussels (ULB-Belgium). He was board certified in dermatology from the University of Lille (France) and completed a fellowship in dermatology from the University of California San Francisco (UCSF-USA). Dr. Marrakchi is a consultant dermatologist in the university hospital of Sfax Tunisia. He works mainly on contact dermatitis and genetics of psoriasis. Dr. Marrakchi published more than 50 scientific articles and 10 books chapters.
Chi-Chiu Mok is currently the chief of the Division of Rheumatology, Department of Medicine, Tuen Mun Hospital, Hong Kong. He is a consultant physician and adjunct teaching professor of the Chinese University of Hong Kong.
As an active researcher, Dr. Mok is the first author of more than 200 papers in a number of medical and Rheumatology journals that include the Annals of the Rheumatic Diseases, Nature Review Rheumatology, Arthritis and Rheumatology, Rheumatology (Oxford), and Arthritis Care & Research. His research interests include systemic lupus erythematosus, particularly lupus nephritis, and glucocorticoid induced osteoporosis. Dr. Mok is also the principal investigator of more than 10 phase II/III global trials investigating the safety and efficacy of novel biological agents in various rheumatic diseases.
Dr. Mok is currently the senior associate editor of the International Journal of Rheumatic Diseases and an editorial board member of more than 10 medical journals that include the Journal of Rheumatology, Lupus, Current Rheumatology Review, Open Orthopedic Journal and Immunology and Immunogenetic Insights.
Prof. Ozdemir did Ph.D. Degree in Electrical Engineering from the University of Kocaeli, Department of Electrical Engineering, (Izmit, Turkey) in 1998. He did M.Sc. in Electrical Engineering from Technical University of Yildiz. He joined as a Lecturer, then became Assistant Professor and Associate Professor at the Kocaeli University. He then became a Professor in the same University in 2013. He was a Visiting Professor in The University of Tennessee, The Center for Ultra-wide-area Resilient Electric Energy Transmission Networks in 2013. He has attended a number of Seminars, meetings and workshops. He is also a member of a number of organizations. He has supervised 5 M.Sc. and 6 Ph.D. theses. He has a number of scientific articles to his credit. His focus of interest is Power Electronics, Power Quality, Electrical Energy Storage, Active Power Filters, DC-DC Converters, Multilevel Inverters, Distributed Energy Resources, PLC, SCADA and industrial automation systems, PV power production (Solar energy systems), Renewable Energy Systems Energy storage technologies for renewable energy support.
Alberto Papi is a Professor of Respiratory Medicine and Vice President in the School of Medicine at the University of Ferrara, Italy, and Director of the Respiratory Unit of the Department of Emergency Medicine, S. Anna University Hospital, Ferrara, Italy. He trained in Respiratory Medicine from the University of Parma, before spending 4 years in the UK as a Clinical Research Fellow at the University of Southampton, where he is an Honorary Clinical Lecturer. He has coordinated several pivotal studies in asthma and COPD, and has authored more than 200 articles in peer-reviewed journals.
GISELLE PENTON ROL is a Senior Researcher at the Center for Genetic Engineering and Biotechnology (CIGB) Havana, Cuba since 2014. She has also been serving as a Full Professor (Titular) of Clinical Biochemistry at the Higher Institute of Medical Sciences (HIMS), Havana, Cuba since 2014. Since 2014 She has been the first/ second degree specialist in Clinical Biochemistry at HIMS, Havana, Cuba. She is editorial board member of the Recent Patents on Inflammation & Allergy Drug Discovery from 2016. She has also been a member of the Italian Cooperation Group for Immunology and Senior member of the Cuban Society of Immunology. Dr. Rol has received several awards such as National Science and Technology Program Project (PNCT) Award and Congress Posters Awards 2006, 2011, 2012, 2013. She has around 28 scientific papers, 2 books and 3 patents to her credit.
Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of International Affairs, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Deputy President of the Research Center for Immunodeficiencies. He is also the founding President of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than 50 research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is an editorial board member of more than 30 international journals. He has edited more than 30 international books, has presented more than 500 lectures/posters in congresses/meetings, and has published more than 800 articles in the international scientific journals.
Dr. Yohannes Tesfaigzi has a doctorate in molecular biology (Ph.D.) from the University of Hohenheim in Stuttgart, Germany. After his postdocoral research at the University of California at Davis, he joined the Lovelace Respiratory Research Institute (LRRI) in Albuquerque, USA in 1994. He is Senior Scientist and Director of the COPD Program at LRRI and Adjunct Professor in the Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine. His research was continuously funded by grants from the National Institutes of Health (NIH)for the past 21 years. Dr. Tesfaigzi has published over 120 peer review publications.
Christina Tsitsimpikou is a Senior governmental officer in the General Chemical State Laboratory of Greece and a professor in the Post-Graduate Course of Toxicology, University of Thessaly. She has BSc in Chemistry, MSc on Pharmacognosy and Sports Medicine, PhD Degree in Biotechnology and post-doctoral thesis on Bioethics. She is General Secretary of the Hellenic Society of Toxicology and European Registered Toxicologist (ERT), with long-term duties in WADA Ethics and Education Committee, the Monitoring Group of the Anti-Doping Convention (T-DO) and the RAC of the European Chemicals Agency. She has published more than 50 articles in peer-reviewed scientific journals.
Dr. Yilmaz is a lecturer in the Faculty of Medicine at Dokuz Eylul University since 1999. He is still working as a manager in Experimental Research Center. He has 203 publications published in international journals. These publications are cited 3700 times. His research areas are laboratory animal science and translational medicine. He is head of the experimental animal ethical committee. He is the president of laboratory animal science association of TURKEY.
Dr. Abdelbaset-Ismail is currently working as associate professor at Surgery Department, Faculty of Veterinary Medicine, Zagazig University, Egypt. He previously worked at the University of Veterinary Medicine Hannover, Germany from November 2008 to February 2011 to conduct the PhD research on regenerative medicine using adipose derived-MSCs. His postdoctoral studies at Stem Cell Institute, James Graham Brown Cancer Center, University of Louisville, KY, USA were mainly targeted on various experimental setups using hematopoietic stem cells, bone marrow, cord blood-derived and adipose tissue-derived MSCs, very small embryonic-like stem cells, leukemic cells, and germline-derived cells. His research interests include stem cells, leukemia, hematopoiesis, veterinary anesthesiology and experimental surgery.
Dr. Rahul Pratap Singh earned his B. Pharm. and M. Pharm. degrees from Bundelkhand University, Jhansi, India. He completed his Ph.D. in Pharmaceutics in 2017, under the supervision of Dr. M.S. Muthu and Prof. B.L. Pandey from Banaras Hindu University, Varanasi. Dr. Singh is an Assistant Professor in the Department of Pharmacy, School of Medical and Allied Sciences, GD Goenka University, Sohna, Gurgaon, India. He has authored dozens of scientific publications and currently editing one book on lung cancer nanomedicines. He received several fellowships; awards including research grant from Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India, Dr. Singh is working as a research project reviewer in the Department of Science and Technology, New Delhi since 2017. He is an Editor-Board Member of several other scientific journals, including Coronaviruses, Current Protein & Peptide Science, Acta Scientific Pharmaceutical Sciences and International Research Journal of Pharmacology.
Dr. Wang received his Ph.D. from the University of Wyoming in Animal Science. She studied the impact of environmental agents and obesity on the intestinal inflammatory responses. Her postdoctoral studies, from the University of Texas Medical Branch and Health Science Center, were mainly focused on impact of various agents on immune dysregulation and cardiovascular diseases. Currently, she is working on the mechanism of environmental toxicant trichloroethylene (TCE)-mediated autoimmunity in Systemic Lupus Erythematosus and autoimmune hepatitis.
Consolato M. Sergi is a Full Professor of Pathology and Pediatrics, University of Alberta, Edmonton, Canada. He obtained his MD degree with honors, Pediatrics residency, and Fellowship in Pediatric Pathology from the University of Genoa, Italy, did his M.Sc. in Public Health from Austria, and FRCPC (Pathology) from the Royal College in Ottawa. Dr. Sergi’s areas of interest are congenital heart disease, metabolic diseases, gastrointestinal/biliary diseases, carcinogenesis (bone/liver), and mitochondrial DNA‐related cardiomyopathies.